{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-082895","form_type":"8-K","ticker":"GRDX","cik":"0001604191","company_name":"GridAI Technologies Corp.","filed_at":"2023-07-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.519647+00:00","generated_at":"2026-06-13T04:57:35.571655+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"First Wave BioPharma prices $2.1M public offering of stock and warrants at $0.64/unit","bullets":["Offering includes 3,285,000 shares (or pre-funded warrants) and warrants to buy up to 6,570,000 shares.","Combined public offering price of $0.64 per share (or pre-funded warrant) and two accompanying warrants.","Warrants have exercise price of $0.64, immediately exercisable, expire in 5 years.","Net proceeds approximately $1.8 million; expected closing July 21, 2023.","Roth Capital Partners acting as exclusive placement agent; proceeds for working capital."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-082895","json":"https://secwatch.observer/filing/0001104659-23-082895.json","markdown":"https://secwatch.observer/filing/0001104659-23-082895.md","text":"https://secwatch.observer/filing/0001104659-23-082895.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923082895/0001104659-23-082895-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923082895/tm2321782d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T04:57:35.571655+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0a84db89a1b17e6f2a5fccf920c3ac078a010e9c","claim":"GridAI Technologies Corp. entered into Placement Agency Agreement with Roth Capital Partners, LLC (effective 2023-07-18).","evidence_excerpt":"On July 18, 2023, First Wave BioPharma, Inc. (the “Company”) entered into a placement agency agreement (the “Placement Agency Agreement”) with Roth Capital Partners, LLC (the “Placement Agent”)","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923082895/0001104659-23-082895-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"Roth Capital Partners, LLC"},{"label":"Effective","value":"2023-07-18"}],"fact_type":"material_agreement"},{"claim_id":"fe86b4b3b5f7f8505a0acb1cb1d507a8242524d5","claim":"GridAI Technologies Corp. entered into Purchase Agreement with certain purchasers valued at approximately $1.8 million (effective 2023-07-18).","evidence_excerpt":"ith Roth Capital Partners, LLC (the “Placement Agent”) and a securities purchase agreement (the “Purchase Agreement”) with certain purchasers pursuant to which the Company agreed to sell, in a best efforts public offering (the “Offering”),","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923082895/0001104659-23-082895-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain purchasers"},{"label":"Value","value":"approximately $1.8 million"},{"label":"Effective","value":"2023-07-18"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}